Ticker,Title,Link
PBYI,Puma Biotech confirms court ruling on patent dispute with AstraZeneca,8/15/2024 1:40:39 PM
PBYI,Puma Biotech drops after patents ruled invalid in fight with AstraZeneca over Tagrisso,8/14/2024 5:32:50 PM
PBYI,Pfizer Tagrisso patent case against AstraZeneca upheld by judge,8/7/2024 4:28:39 PM
PBYI,Puma Biotechnology: A Buy Rating Reinforced by Strong Q2 Performance and Solid Prospects for Flagship Product Nerlynx,8/2/2024 10:17:18 AM
PBYI,"Puma Biotechnology Non-GAAP EPS of -$0.05 beats by $0.05, revenue of $47.1M beats by $2.4M",8/1/2024 8:35:14 PM
PBYI,Puma Biotechnology earnings: here's what Wall Street expects,7/31/2024 3:01:13 PM
PBYI,Optimistic Outlook for Puma Biotechnology: Buy Rating Justified by Strong Product Performance and Promising Pipeline,7/26/2024 2:55:18 PM
PBYI,Beyond The Numbers: 4 Analysts Discuss Puma Biotechnology Stock,6/4/2024 5:01:45 PM
PBYI,Buy Rating Reaffirmed for Puma Biotechnology Amid Promising Alisertib Developments and Orphan Drug Designation,6/3/2024 10:15:51 AM
PBYI,TD Cowen Sticks to Its Hold Rating for Puma Biotechnology (PBYI),5/20/2024 11:17:29 AM
PBYI,Puma Biotech pares gain amid Wyeth victory in Tagrisso patent case against AstraZeneca,5/17/2024 7:10:02 PM
PBYI,Puma Biotechnology's Q1 Earnings and Revenues Beat,5/3/2024 10:00:34 PM
PBYI,"Puma Biotechnology Non-GAAP EPS of -$0.05 beats by $0.10, revenue of $43.8M misses by $5.25M",5/2/2024 8:34:32 PM
PBYI,Puma Biotechnology Q1 2024 Earnings Preview,5/1/2024 9:35:51 PM
PBYI,7 Stocks Under $15 Predicted to Boom in the Next 2 Years,4/19/2024 11:13:00 AM
PBYI,Puma Biotech cleared to trial Takeda-partnered breast cancer therapy in U.S.,3/20/2024 2:06:37 PM
PBYI,"COIN, HUT and WNW among pre-market losers",3/19/2024 12:44:21 PM
PBYI,Puma Biotechnology dips after dismissal of its suit was granted by a federal judge,3/18/2024 7:36:31 PM
PBYI,Buy Rating on Puma Biotechnology Amid Financial Challenges and Drug Advancement Prospects,3/1/2024 1:37:27 PM
PBYI,"ADSK, NTAP and RILY are among after hour movers",2/29/2024 10:14:08 PM
PBYI,Notable earnings after Thursday's close,2/28/2024 10:35:08 PM
PBYI,"Analysts Are Bullish on Top Healthcare Stocks: Puma Biotechnology (PBYI), ESSA Pharma (EPIX)",2/13/2024 4:10:35 PM
PBYI,3 Strong Buy Stocks Under $5: January 2024,1/31/2024 5:58:26 PM
PBYI,Edward White’s Buy Rating for Puma Biotechnology: Strong Financial Performance and Promising Market Potential for Nerlynx,11/3/2023 10:22:23 AM
PBYI,Puma Biotechnology earnings: here's what Wall Street expects,11/1/2023 3:01:13 PM
PBYI,Buy Rating for Puma Biotechnology: Key Factors and Financial Prospects,10/16/2023 10:28:42 AM
PBYI,"Analysts Offer Insights on Healthcare Companies: Rani Therapeutics Holdings (RANI), Puma Biotechnology (PBYI) and BeiGene (BGNE)",9/20/2023 10:22:54 AM
PBYI,Puma Biotechnology lung cancer candidate IND cleared by FDA,8/8/2023 1:11:23 PM
PBYI,H.C. Wainwright Remains a Buy on Puma Biotechnology (PBYI),8/4/2023 10:35:16 AM
PBYI,"Puma Biotechnology Non-GAAP EPS of $0.05 misses by $0.02, revenue of $54.6M beats by $2.87M",8/3/2023 8:51:24 PM
PBYI,Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday,7/20/2023 11:27:03 AM
PBYI,H.C. Wainwright Keeps Their Buy Rating on Puma Biotechnology (PBYI),6/5/2023 10:15:09 AM
PBYI,"QCOM, EGHT and PBYI are among after hour movers",5/22/2023 9:30:42 PM
PBYI,"Nanobiotix, Owens & Minor top healthcare gainers; Soligenix, DermTech among losers",5/5/2023 2:07:04 PM
PBYI,"Puma Biotechnology Non-GAAP EPS of $0.09, revenue of $52.8M",5/4/2023 8:48:10 PM
PBYI,Notable earnings after Thursday's close,5/3/2023 9:35:33 PM
PBYI,Why Bed Bath & Beyond Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session,3/30/2023 6:43:14 PM
PBYI,H.C. Wainwright Keeps Their Buy Rating on Puma Biotechnology (PBYI),3/14/2023 3:15:04 PM
PBYI,"Analysts Offer Insights on Healthcare Companies: Cytokinetics (CYTK), Puma Biotechnology (PBYI) and Praxis Precision Medicines (PRAX)",3/6/2023 11:20:24 AM
PBYI,Why Puma Biotechnology Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session,3/3/2023 7:20:34 PM
PBYI,"Puma Biotechnology reports Q4 results, provides Q1, FY 2023 guidance",3/2/2023 9:14:49 PM
PBYI,Puma Biotechnology Q4 2022 Earnings Preview,3/1/2023 10:35:51 PM
PBYI,7 A-Rated Penny Stocks Worth Betting On,2/19/2023 7:05:18 PM
PBYI,H.C. Wainwright Reaffirms Their Buy Rating on Puma Biotechnology (PBYI),2/1/2023 3:45:28 PM
PBYI,Puma Biotechnology settles with Novartis' Sandoz unit over Nerlynx patent dispute,12/16/2022 10:00:18 PM
PBYI,H.C. Wainwright Sticks to Its Buy Rating for Puma Biotechnology (PBYI),12/8/2022 3:55:09 PM
PBYI,Why Richardson Electronics Shares Surged Over 8%; Here Are 55 Biggest Movers From Friday,11/28/2022 11:09:25 AM
PBYI,Why Drive Shack Shares Jumped Over 23%; Here Are 76 Biggest Movers From Yesterday,11/22/2022 9:49:21 AM
PBYI,S&P 500 Down 1%; Crude Oil Drops Sharply,11/17/2022 6:07:13 PM
PBYI,Why MediaAlpha Shares Jumped Around 30%; Here Are 112 Biggest Movers From Friday,11/7/2022 9:07:41 AM
PBYI,"Puma soars 17% as breast cancer drug Nerlynx drives Q3 sales, raises outlook",11/4/2022 4:09:12 PM
PBYI,"Puma Biotechnology Non-GAAP EPS of $0.05, revenue of $57.1M",11/3/2022 8:28:12 PM
PBYI,Puma Biotechnology Q3 2022 Earnings Preview,11/2/2022 9:35:59 PM
PBYI,H.C. Wainwright Reaffirms Their Buy Rating on Puma Biotechnology (PBYI),10/27/2022 2:25:35 PM
PBYI,Analysts Offer Insights on Healthcare Companies: Puma Biotechnology (PBYI) and Iterum Therapeutics (ITRM),9/21/2022 10:30:44 AM
PBYI,"Puma Biotechnology, Takeda enter licensing agreement for cancer treatment alisertib",9/20/2022 8:37:52 PM
PBYI,"Puma Biotechnology Non-GAAP EPS of $0.28, revenue of $59.5M",8/4/2022 8:44:40 PM
PBYI,Here's what Wall Street expects from Puma Biotechnology's earnings,8/3/2022 3:01:13 PM
PBYI,69 Biggest Movers From Friday,6/6/2022 11:31:42 AM
PBYI,"Bluebird Bio, Clovis Oncology, Chimerix drop as Truist flags liquidity concerns",6/2/2022 1:59:50 PM
PBYI,"Puma Biotechnology Non-GAAP EPS of -$0.01 beats by $0.10, revenue of $45.7M beats by $0.63M",5/5/2022 8:42:06 PM
PBYI,Notable earnings after Thursday's close,5/4/2022 9:35:55 PM
PBYI,"TERN, SOHO and CLSD among after hour movers",3/21/2022 9:26:55 PM
PBYI,"Atreca, Alignment top healthcare gainers; DBV Technologies, Ocugen lead losers' pack",3/4/2022 3:00:50 PM
PBYI,Puma Biotechnology up 15% after quarterly earnings beats,3/3/2022 10:27:50 PM
PBYI,Notable earnings after Thursday's close,3/2/2022 10:35:28 PM
PBYI,"The Week Ahead In Biotech (Feb. 27-March 5): Earnings, Multiple Regulatory Decisions Take The Spotlight",2/27/2022 3:26:47 PM
PBYI,Puma Biotechnology grants inducement awards to one new employee,1/21/2022 11:16:49 AM
PBYI,"The Daily Biotech Pulse: Adagio's Antibody Effective Against Omicron, Sarepta Terminates Gene Therapy Deal, AstraZeneca Inks Oncology Pact",1/13/2022 2:18:12 PM
PBYI,"Puma Biotechnology, Marin Software lead aftermarket gainers; Vaxcyte among losers",1/12/2022 10:14:34 PM
PBYI,"The Daily Biotech Pulse: Lilly Sings Metabolic Disorder Drug Pact, Moderna Reports Positive Flu Vaccine Data, Halozyme To Buy Back Shares",12/10/2021 1:50:11 PM
PBYI,"The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More",12/6/2021 12:07:24 PM
PBYI,"The Daily Biotech Pulse: Kura's Blood Cancer Drug Study Gets Partial Clinical Hold, Takeda FDA Nod, Puma Breast Cancer Treatment Gets Patent Extension",11/24/2021 1:32:06 PM
PBYI,Puma Biotechnology wins extension for U.S. patent related to breast cancer therapy,11/23/2021 9:20:59 PM
PBYI,"Pre-market Movers: ASTR, VG, CEI, CMBM, PTNR… ",11/22/2021 1:37:35 PM
PBYI,92 Biggest Movers From Friday,11/8/2021 9:42:50 AM
PBYI,ADGI and LBPS among mid-day movers,11/5/2021 5:55:56 PM
PBYI,RDBX among after hour movers,11/4/2021 10:01:55 PM
PBYI,Puma Biotechnology Q3 2021 Earnings Preview,11/3/2021 9:35:36 PM
PBYI,"The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline",10/31/2021 7:23:54 PM
PBYI,"The Daily Biotech Pulse: Entasis, Dermata Spike Higher On Positive Readouts, J&J Q3 EPS Beats Estimates, Wave Life Sciences Regains Right To CNS Portfolio",10/19/2021 2:23:01 PM
PBYI,"The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal",10/6/2021 1:33:33 PM
PBYI,"The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout",10/5/2021 2:01:45 PM
PBYI,"Benzinga's Top Ratings Upgrades, Downgrades For September 28, 2021",9/28/2021 4:11:29 PM
PBYI,"The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO",8/6/2021 1:42:39 PM
PBYI,"Puma Biotechnology EPS beats by $0.46, beats on revenue",8/5/2021 8:24:45 PM
PBYI,Notable earnings after Thursday's close,8/4/2021 9:35:49 PM
PBYI,Puma Biotechnology earnings preview: what Wall Street is expecting,8/3/2021 3:02:13 PM
PBYI,Cowen initiates Celcuity with an outperform rating on breast cancer diagnostic,7/29/2021 5:28:54 PM
PBYI,Puma Biotechnology enters into $125M note purchase transaction with Athyrium Capital,7/26/2021 1:25:24 PM
PBYI,Puma Biotech's Nerlynx Wins Canadian Approval In HER2-Positive Metastatic Breast Cancer,7/6/2021 4:23:58 PM
PBYI,FDA Approves Dose Escalation Label Update For Puma's NERLYNX In Metastatic Breast Cancer ,7/1/2021 3:09:25 PM
PBYI,Puma Bio's neratinib extended therapy improves overall survival in early stage HER2+ breast cancer patients,6/4/2021 1:42:26 PM
PBYI,"VRAY, GRPN, FROG and AUPH among after-hours movers",5/6/2021 9:44:39 PM
PBYI,"Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge",5/1/2021 7:19:25 PM
PBYI,"The Daily Biotech Pulse: Merck's Keytruda Gets Label Expansion In Europe, Pfizer To Sell Chinese Biologics Unit, Celcuity Spikes",3/17/2021 12:43:08 PM
PBYI,Celcuity enters clinical trial collaboration in mid-stage breast cancer study,3/16/2021 8:07:02 PM
PBYI,"The Daily Biotech Pulse: Adcom Test Awaits J&J's COVID-19 Vaccine, Lilly To Supply Additional Antibody Therapy Doses To US, Regulatory Setback For Tricida",2/26/2021 2:16:52 PM
PBYI,Puma Biotechnology and Pierre Fabre amend NERLYNX license agreement,2/25/2021 9:12:04 PM
PBYI,Puma Biotechnology Q4 2020 Earnings Preview,2/24/2021 10:35:49 PM
PBYI,What Wall Street expects from Puma Biotechnology's earnings,2/23/2021 3:01:52 PM
PBYI,"The Week Ahead In Biotech: J&J Vaccine Adcom Meeting, Sarepta FDA Decision And Plenty Of Earnings",2/20/2021 3:36:28 PM
PBYI,Puma Bio up 6% after reporting neratinib data in lung cancer,1/29/2021 2:01:04 PM
PBYI,Puma Bio's neratinib shows encouraging effect in biliary tract cancers,1/15/2021 1:51:50 PM
PBYI,"The Daily Biotech Pulse: Moderna Coronavirus Vaccine Receives Third Regulatory Nod, Gritstone Rallies On Hedge Fund Stake, aTyr's COVID-19 Drug Data",1/5/2021 2:38:54 PM
PBYI,"AAME, AIH, GDS and VRAY among after-hours movers",1/4/2021 10:54:49 PM
PBYI,Celcuity inks clinical trial pact with Massachusetts General Hospital and Puma Technologies,12/23/2020 12:47:21 PM
PBYI,Puma Biotech's neratinib shows improved CNS outcomes in late-stage breast cancer study,12/11/2020 7:57:50 PM
PBYI,Puma Bio's neratinib meaningful reduces risk of recurrence and improves survial in early stage breast cancer patients,12/10/2020 7:12:29 AM
PBYI,Puma Biotechnology says European patent board upholds patent covering EGFR inhibitors,12/2/2020 4:59:40 PM
PBYI,Notable earnings after Thursday's close,11/4/2020 10:35:58 PM
PBYI,Puma Bio's neratinib shows incremental survival benefit in late-stage breast cancer study,10/5/2020 8:51:54 PM
PBYI,Here's what Wall Street expects from Puma Biotechnology's earnings,8/5/2020 3:04:13 PM
PBYI,Healthcare - Top 5 Gainers/Losers,5/8/2020 3:01:27 PM
PBYI,Puma Biotechnology earnings preview: what to expect,5/7/2020 3:02:03 PM
PBYI,"BYND, ALC among premarket gainers",2/26/2020 2:13:36 PM
PBYI,"ZS, FSLR among premarket losers",2/21/2020 2:18:33 PM
PBYI,"Puma Biotechnology EPS beats by $0.27, beats on revenue",2/20/2020 9:09:31 PM
PBYI,Puma Biotechnology earnings preview: what to expect,2/19/2020 3:01:51 PM
PBYI,"BTU, VVUS, TSLA and ZIOP among midday movers",2/5/2020 5:45:59 PM
PBYI,"GILD's KTE-X19 To Face FDA, NTEC Drops As NVS Walks Away, KZIA On Watch ",12/12/2019 3:39:53 AM
PBYI,Puma Biotechnology is about to announce its earnings — here's what to expect,8/6/2019 3:03:04 PM
PBYI,What Wall Street expects from Puma Biotechnology's earnings,5/7/2019 3:03:15 PM
PBYI,What Wall Street expects from Puma Biotechnology's earnings,2/26/2019 3:02:00 PM
PBYI,"TRPX On A High, PBYI Braces For Busy Times Ahead, NVCN On Watch ",11/6/2018 1:25:34 AM
PBYI,Puma Biotechnology earnings: here's what Wall Street expects,10/30/2018 3:03:29 PM
PBYI,EC Grants Marketing Authorisation For Puma Biotechnology's NERLYNX ,9/4/2018 2:24:19 PM
PBYI,"SPRO To Report Data In Q3, ITRM Takes Steady And SURE Steps, PBYI On Watch ",8/10/2018 10:38:45 AM
PBYI,"SPHS Rebounds, ACHV Soars On New Data, PBYI Gains On CHMP Opinion, SPPI Abuzz ",6/27/2018 3:50:59 AM
PBYI,Champions Oncology Partners with Puma Biotechnology and NSABP Foundation on Metastatic Breast and Colon Cancer Co-clinical PDX Studies,6/18/2018 2:30:00 PM
PBYI,BRIEF-Puma Biotechnology Q1 Loss Per Share $0.65,5/9/2018 10:30:52 PM
PBYI,Don't Let the Check Engine Light Turn You Off From Making Needed Repairs,5/1/2018 5:57:00 PM
PBYI,BRIEF-Puma Biotechnology And Pint Pharma Enter Licensing Agreement To Commercialize Nerlynx In Latin America,4/3/2018 2:47:39 PM
PBYI,BRIEF-Puma Biotechnology ‍Nerlynx Included As Recommended Treatment Option In NCCN Clinical Practice Guidelines,4/2/2018 3:09:04 PM
PBYI,"AMRN Looks Forward To Big Event, PBYI Plunges After-hours, SPARC Lights Up CERS ",1/24/2018 7:00:01 AM
PBYI,"New Early- Breast Cancer Drug to be Made Available in Australia, New Zealand and South East Asia Following License Deal",11/22/2017 3:30:00 PM
PBYI,"Stocks Under Scanner in the Biotech Space -- Puma Biotech, Regeneron Pharma, Sarepta Therapeutics, and Seattle Genetics",9/14/2017 12:50:00 PM
PBYI,"Consumer Watchdog Praises Tech Giant Oracle Support for Amending Internet Law to Stop Sex Trafficking; Challenges Google, Facebook, Twitter, Amazon and Yelp! to Act in Public's Interest",9/7/2017 3:00:00 PM
PBYI,"ACHV Focuses On Achievement, IMGN Strikes Chord With JAZZ, FDA Snubs ACOR ",8/30/2017 5:18:07 AM
PBYI,"Breakfast Technical Briefing on Biotech Stocks -- Pacific Biosciences of California, Puma Biotechnology, PDL BioPharma, and Progenics Pharma",8/3/2017 12:25:00 PM
PBYI,Biotech Stocks Facing FDA Decision In August ,7/31/2017 7:47:51 AM
PBYI,"Gainers & Losers Of July 18: CAPR, NVAX, TTOO, IMUC, SBPH... ",7/19/2017 4:37:03 AM
PBYI,"FDA Nod For PBYI, ANIK Sees 23-26% Revenue Growth, CBAY Abuzz, RPRX Plunges ",7/18/2017 9:42:57 AM
PBYI,"BMY's Orencia Scores Another FDA Nod, Janssen Ends Deal With CAPR, PBYI On Track ",7/7/2017 7:36:45 AM
PBYI,Biotech Stocks Facing FDA Decision In July ,6/29/2017 6:48:24 AM
PBYI,Puma Biotechnology Holding On To Strong Gain In Afternoon Trading ,6/5/2017 7:58:35 PM
PBYI,"AERI Is Awesome, GWPH Abuzz, FDA Panel Nod For PBYI ",5/25/2017 7:30:08 AM
PBYI,"Gainers & Losers Of May 23: GLYC, PBYI, SGMO, CERS, AGLE... ",5/24/2017 3:47:50 AM
PBYI,"FDA Approves 1st Drug For GCA, Puma Leaps, Will SBPH Spring A Surprise? ",5/23/2017 6:02:36 AM
PBYI,"Gainers & Losers Of May 17: SNDX, PULM, PBYI, CNCE, XLRN... ",5/18/2017 4:23:04 AM
PBYI,"SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Puma Biotechnology, Inc. of Class Action Lawsuit and Upcoming Deadline - PBYI",5/13/2017 12:45:00 AM
PBYI,"SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Puma Biotechnology, Inc. (PBYI) and Lead Plaintiff Deadline: July 7, 2017",5/11/2017 7:53:00 PM
PBYI,"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Puma Biotechnology, Inc. - PBYI",5/5/2017 4:19:00 PM
PBYI,"OMED Disappoints, PBYI Soars, AMAG Seeks Expanded Approval For Makena ",4/18/2017 7:37:22 AM
PBYI,"Biotech Stocks on Investors' Radar -- Puma Biotechnology, Regeneron Pharma, Calithera, and Lexicon Pharma",4/5/2017 12:55:00 PM
PBYI,"FDA Approves Odactra, JUNO Abandons Rocket, VRML Abuzz, No Tremors For NDRM ",3/2/2017 11:13:18 AM
PBYI,"Research Reports Coverage on Biotech Stocks -- Puma Biotechnology, Dipexium Pharma, BioCryst Pharma, and CTI BioPharma",2/24/2017 1:15:00 PM
